Nestle wants to sell its skin health unit, as the company wants to focus mainly on food, drinks and nutritional health.
The Swiss company’s skin health unit (which produces Cetaphil and Proactiv skin care brands and Restylane wrinkle fillers) had sales of 2.7 billion Swiss francs ($2.8 billion) last year, which is around 3 percent of Nestle’s total sales. The skin treatments business is reportedly facing challenges from generic competition. Keen on concentrating on its food and healthcare segments, Nestle said, “the future growth opportunities of Nestle Skin Health lie increasingly outside the group’s strategic scope”. Also, Nestle agreed to sell its Gerber Life Insurance business for $1.55 billion, while a Reuters report suggested that it might be bidding for GlaxoSmithKline’s Horlicks drink.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.